About Careers Internship MedBlog Contact us

Screening Tests for Tuberculosis

Last Updated on Feb 20, 2014
Font : A-A+


Tuberculosis is a major health care problem in the developing world. According to the WHO, a total of 9,400,000 new cases were diagnosed throughout the world in 2010. 30% of these cases were diagnosed in Africa whereas 35% were detected in South East Asia. The disease resulted in 1,300,000 deaths in 2010. People with decreased immunity are particularly susceptible, especially those with HIV. Resistance to anti-tuberculosis treatment also adds to the problem.

Tuberculosis Screening Test

Who should undergo screening for tuberculosis?

People at high risk of contacting tuberculosis are advised to undergo screening for the disease. These include:

  • People living or working in close contact with tuberculosis patients
  • HIV patients and other people with decreased immunity
  • People living in areas where tuberculosis is very common i.e. most countries in Africa, Asia, Latin America and the Caribbean, Eastern Europe, and Russia
  • People living under conditions where tuberculosis spreads easily e.g. prisons
  • Drug addicts who inject drugs

Which tests are used for screening for tuberculosis?

Tests used to screen persons for tuberculosis include the tuberculin skin test and the Interferon – Release Assays

Tuberculin Skin Test (TST): Tuberculin skin test is also called as the Mantoux test, Pirquet test or the PPD test. In this test, a small test dose is injected between the layers of the skin (intrdermally) and the area is marked. After 48 to 72 hours, the area is checked for any induration (hard swelling).

  • An induration of more than 10 mm indicates a positive test and is seen in patients exposed to the tuberculosis bacteria.
  • An induration of more than 5 mm may be considered positive in patients with HIV or low immunity.
  • False negative reactions occur in people with low immunity or with severe infection.
  • False positive reactions may occur in patients with prior BCG vaccination and patients with infections caused by non tubercular mycobacteria.

Interferon - Release Assays: These are blood tests used to detect tuberculosis. When the blood of patients is incubated with certain proteins of TB bacteria, the immune cells from the patient’s blood release a substance called interferon. This is detected during these tests. Tests that are commercially available include the QuantiFERON – TB Gold, QuantiFERON-TB Gold In-Tube test (QFT-GIT) and T.SPOT.TB test.

False positive reactions in patients with BCG vaccination or with infections caused by non tubercular mycobacteria are less likely to occur with these tests.

These tests require less frequent visits to the hospital and results are available within 24 hours.

They do not require measurement of skin induration, which could be highly subjective and lead to errors.


They are highly specific for tuberculosis. In addition, they do not boost responses to subsequent tests. These tests may not be preferred in children less than 5 years. They are also more expensive.

Frequently Asked Questions

1. When should I call a doctor?

A consultation with your physician or tuberculosis specialist is advised if the results of the above tests come as abnormal.

2. What is meant by false positive and false negative test?

A false positive test means that the test has turned positive despite the patient not suffering from the disease. A false negative test means that the person suffers from the disease, yet the test has given a negative result.

3. Which of the above test is preferred?

The blood tests are preferred over the tuberculin test. However, they are expensive and may not be feasible to be carried out on a large number of people especially in the underdeveloped countries. They should also not be conducted in children less than 5 years.

4. My tuberculin test shows a red area but no induration. Is it positive?

No. Induration is necessary to read the test as positive.

References: close

Citations   close

Latest Publications and Research on Screening Tests for Tuberculosis

Do you wish to consult a General Medicine Doctor / Internal Medicine Doctor for your problem? Ask your question

Dr. Abhani Brijesh
Dr. Abhani Brijesh
3 years experience
Christ, Madhapar, Rajkot
Dr. Gayathri Vijayalakshmi
Dr. Gayathri Vijayalakshmi
12 years experience
View All

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.



TB is a global health problem most especially in developing countries. Screening tests for TB such as the Mantoux test in already expensive for the people living in developing countries. Hopefully, governments can provide free TB screening.

Recommended Reading
Health Topics A - Z

    What's New on Medindia
    Quiz on Low-Calorie Diet for Diabetes
    World Heart Day in 2022- Use Heart for Every Heart
    Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
    View all

    Medindia Newsletters Subscribe to our Free Newsletters!
    Terms & Conditions and Privacy Policy.

    Most Popular on Medindia

    Nutam (400mg) (Piracetam) Color Blindness Calculator Sanatogen Drug Interaction Checker Loram (2 mg) (Lorazepam) Selfie Addiction Calculator Accident and Trauma Care Turmeric Powder - Health Benefits, Uses & Side Effects Sinopril (2mg) (Lacidipine) A-Z Drug Brands in India
    This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use